SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma
Clinical trial NCT03138161 · RECRUITING
Trial details
- NCT number
- NCT03138161
- Sponsor
- Sarcoma Oncology Research Center, LLC
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-13
- Primary completion
- 2030-12-31
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.